Integrated cardiac safety: assessment methodologies for noncardiac drugs in discovery, development, and postmarketing surveillance
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Hoboken, N.J.
John Wiley & Sons
c2009
|
| Schlagworte: | |
| Beschreibung: | Includes bibliographical references (p. 397-455) and index |
| Beschreibung: | xxviii, 470 p. |
| ISBN: | 0470229640 9780470229644 |
Internformat
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV044131453 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 170217s2009 |||| o||u| ||||||eng d | ||
| 020 | |a 0470229640 |c cloth |9 0-470-22964-0 | ||
| 020 | |a 9780470229644 |c cloth |9 978-0-470-22964-4 | ||
| 035 | |a (ZDB-30-PAD)EBC406462 | ||
| 035 | |a (ZDB-89-EBL)EBL406462 | ||
| 035 | |a (OCoLC)317483524 | ||
| 035 | |a (DE-599)BVBBV044131453 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 082 | 0 | |a 616.1/23061 |2 22 | |
| 100 | 1 | |a Turner, J. Rick |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a Integrated cardiac safety |b assessment methodologies for noncardiac drugs in discovery, development, and postmarketing surveillance |c J. Rick Turner, Todd A. Durham |
| 264 | 1 | |a Hoboken, N.J. |b John Wiley & Sons |c c2009 | |
| 300 | |a xxviii, 470 p. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 500 | |a Includes bibliographical references (p. 397-455) and index | ||
| 505 | 0 | |a The importance of cardiac safety assessments -- The biological basis of adverse drug reactions -- Cardiac structure and function -- Cardiac pathophysiology and disease -- Drug discovery and drug design -- Nonclinical development -- The thorough QT/QTc trial -- General safety assessments -- Therapeutic use trials and meta-analyses -- Assessment methodologies in nonexperimental postmarketing surveillance -- Postmarketing proarrhythmic cardiac safety assessments -- Generalized cardiac safety -- Medication errors, adherence, and concordance -- Future directions in drug safety | |
| 650 | 4 | |a Cardiovascular toxicology | |
| 650 | 4 | |a Heart |x Effect of drugs on | |
| 650 | 4 | |a Drugs |x Side effects |x Testing | |
| 650 | 4 | |a Drugs |x Safety measures | |
| 700 | 1 | |a Durham, Todd A. |e Sonstige |4 oth | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe, Hardcover |z 0-470-22964-0 |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe, Hardcover |z 978-0-470-22964-4 |
| 912 | |a ZDB-30-PAD | ||
| 999 | |a oai:aleph.bib-bvb.de:BVB01-029538298 | ||
Datensatz im Suchindex
| _version_ | 1804177220368859136 |
|---|---|
| any_adam_object | |
| author | Turner, J. Rick |
| author_facet | Turner, J. Rick |
| author_role | aut |
| author_sort | Turner, J. Rick |
| author_variant | j r t jr jrt |
| building | Verbundindex |
| bvnumber | BV044131453 |
| collection | ZDB-30-PAD |
| contents | The importance of cardiac safety assessments -- The biological basis of adverse drug reactions -- Cardiac structure and function -- Cardiac pathophysiology and disease -- Drug discovery and drug design -- Nonclinical development -- The thorough QT/QTc trial -- General safety assessments -- Therapeutic use trials and meta-analyses -- Assessment methodologies in nonexperimental postmarketing surveillance -- Postmarketing proarrhythmic cardiac safety assessments -- Generalized cardiac safety -- Medication errors, adherence, and concordance -- Future directions in drug safety |
| ctrlnum | (ZDB-30-PAD)EBC406462 (ZDB-89-EBL)EBL406462 (OCoLC)317483524 (DE-599)BVBBV044131453 |
| dewey-full | 616.1/23061 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.1/23061 |
| dewey-search | 616.1/23061 |
| dewey-sort | 3616.1 523061 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02043nmm a2200409zc 4500</leader><controlfield tag="001">BV044131453</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">170217s2009 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0470229640</subfield><subfield code="c">cloth</subfield><subfield code="9">0-470-22964-0</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780470229644</subfield><subfield code="c">cloth</subfield><subfield code="9">978-0-470-22964-4</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-30-PAD)EBC406462</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-89-EBL)EBL406462</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)317483524</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV044131453</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.1/23061</subfield><subfield code="2">22</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Turner, J. Rick</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Integrated cardiac safety</subfield><subfield code="b">assessment methodologies for noncardiac drugs in discovery, development, and postmarketing surveillance</subfield><subfield code="c">J. Rick Turner, Todd A. Durham</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Hoboken, N.J.</subfield><subfield code="b">John Wiley & Sons</subfield><subfield code="c">c2009</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">xxviii, 470 p.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references (p. 397-455) and index</subfield></datafield><datafield tag="505" ind1="0" ind2=" "><subfield code="a">The importance of cardiac safety assessments -- The biological basis of adverse drug reactions -- Cardiac structure and function -- Cardiac pathophysiology and disease -- Drug discovery and drug design -- Nonclinical development -- The thorough QT/QTc trial -- General safety assessments -- Therapeutic use trials and meta-analyses -- Assessment methodologies in nonexperimental postmarketing surveillance -- Postmarketing proarrhythmic cardiac safety assessments -- Generalized cardiac safety -- Medication errors, adherence, and concordance -- Future directions in drug safety</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cardiovascular toxicology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Heart</subfield><subfield code="x">Effect of drugs on</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drugs</subfield><subfield code="x">Side effects</subfield><subfield code="x">Testing</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drugs</subfield><subfield code="x">Safety measures</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Durham, Todd A.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe, Hardcover</subfield><subfield code="z">0-470-22964-0</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe, Hardcover</subfield><subfield code="z">978-0-470-22964-4</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-30-PAD</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-029538298</subfield></datafield></record></collection> |
| id | DE-604.BV044131453 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T07:44:37Z |
| institution | BVB |
| isbn | 0470229640 9780470229644 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-029538298 |
| oclc_num | 317483524 |
| open_access_boolean | |
| physical | xxviii, 470 p. |
| psigel | ZDB-30-PAD |
| publishDate | 2009 |
| publishDateSearch | 2009 |
| publishDateSort | 2009 |
| publisher | John Wiley & Sons |
| record_format | marc |
| spelling | Turner, J. Rick Verfasser aut Integrated cardiac safety assessment methodologies for noncardiac drugs in discovery, development, and postmarketing surveillance J. Rick Turner, Todd A. Durham Hoboken, N.J. John Wiley & Sons c2009 xxviii, 470 p. txt rdacontent c rdamedia cr rdacarrier Includes bibliographical references (p. 397-455) and index The importance of cardiac safety assessments -- The biological basis of adverse drug reactions -- Cardiac structure and function -- Cardiac pathophysiology and disease -- Drug discovery and drug design -- Nonclinical development -- The thorough QT/QTc trial -- General safety assessments -- Therapeutic use trials and meta-analyses -- Assessment methodologies in nonexperimental postmarketing surveillance -- Postmarketing proarrhythmic cardiac safety assessments -- Generalized cardiac safety -- Medication errors, adherence, and concordance -- Future directions in drug safety Cardiovascular toxicology Heart Effect of drugs on Drugs Side effects Testing Drugs Safety measures Durham, Todd A. Sonstige oth Erscheint auch als Druck-Ausgabe, Hardcover 0-470-22964-0 Erscheint auch als Druck-Ausgabe, Hardcover 978-0-470-22964-4 |
| spellingShingle | Turner, J. Rick Integrated cardiac safety assessment methodologies for noncardiac drugs in discovery, development, and postmarketing surveillance The importance of cardiac safety assessments -- The biological basis of adverse drug reactions -- Cardiac structure and function -- Cardiac pathophysiology and disease -- Drug discovery and drug design -- Nonclinical development -- The thorough QT/QTc trial -- General safety assessments -- Therapeutic use trials and meta-analyses -- Assessment methodologies in nonexperimental postmarketing surveillance -- Postmarketing proarrhythmic cardiac safety assessments -- Generalized cardiac safety -- Medication errors, adherence, and concordance -- Future directions in drug safety Cardiovascular toxicology Heart Effect of drugs on Drugs Side effects Testing Drugs Safety measures |
| title | Integrated cardiac safety assessment methodologies for noncardiac drugs in discovery, development, and postmarketing surveillance |
| title_auth | Integrated cardiac safety assessment methodologies for noncardiac drugs in discovery, development, and postmarketing surveillance |
| title_exact_search | Integrated cardiac safety assessment methodologies for noncardiac drugs in discovery, development, and postmarketing surveillance |
| title_full | Integrated cardiac safety assessment methodologies for noncardiac drugs in discovery, development, and postmarketing surveillance J. Rick Turner, Todd A. Durham |
| title_fullStr | Integrated cardiac safety assessment methodologies for noncardiac drugs in discovery, development, and postmarketing surveillance J. Rick Turner, Todd A. Durham |
| title_full_unstemmed | Integrated cardiac safety assessment methodologies for noncardiac drugs in discovery, development, and postmarketing surveillance J. Rick Turner, Todd A. Durham |
| title_short | Integrated cardiac safety |
| title_sort | integrated cardiac safety assessment methodologies for noncardiac drugs in discovery development and postmarketing surveillance |
| title_sub | assessment methodologies for noncardiac drugs in discovery, development, and postmarketing surveillance |
| topic | Cardiovascular toxicology Heart Effect of drugs on Drugs Side effects Testing Drugs Safety measures |
| topic_facet | Cardiovascular toxicology Heart Effect of drugs on Drugs Side effects Testing Drugs Safety measures |
| work_keys_str_mv | AT turnerjrick integratedcardiacsafetyassessmentmethodologiesfornoncardiacdrugsindiscoverydevelopmentandpostmarketingsurveillance AT durhamtodda integratedcardiacsafetyassessmentmethodologiesfornoncardiacdrugsindiscoverydevelopmentandpostmarketingsurveillance |